Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiSaver in Acute Myocardial Infarction
NCT04050163Phase 2Completed
- Sponsor
- HONYA Medical
- Start
- Jan 2021
- Primary completion
- May 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of MiSaver in acute myocardial infarction (AMI) (3 arms), sponsored by HONYA Medical. Primary endpoint: Incidence of Treatment Emergent Adverse Events at 12 months. Started Jan 2021; status: completed.
02
Drugs
MiSaver
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT04050163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050163.